STING1 and central nervous system cancer: Together, this study demonstrated that nanoagonists activated the cGAS‐STING pathway, synergized immunotherapy and chemotherapy to alleviate glioma, and improved antitumor immune efficacy antitumor immunity, providing emerging opportunities for enhancing the efficacy of immunotherapies (Scheme1).